Role of PARP-1 in Mediating Inflammatory Gene Transcription
PARP-1 在介导炎症基因转录中的作用
基本信息
- 批准号:7149149
- 负责人:
- 金额:$ 30.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-12-01 至 2010-11-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAcuteAdenosine Diphosphate RiboseAlzheimer&aposs DiseaseAutoimmune ProcessBindingCellsCessation of lifeComplexDNA BindingDataDevelopmentDiseaseFigs - dietaryGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionImmune responseInflammationInflammatoryInflammatory ResponseInjuryInterleukin-6KnowledgeLeadLung InflammationMediatingMediator of activation proteinMethodsMolecularMultiple SclerosisNitric Oxide SynthaseOrgan failurePathogenesisPoly Adenosine Diphosphate RibosePoly(ADP-ribose) PolymerasesPreventionProteinsRecruitment ActivityRegulationReportingResearch PersonnelResistanceRoleSeptic ShockSpecificityTestingTissuesdesigninhibitor/antagonistinsightmacrophagemutantnovelpoly(ADP-ribose)polymerase-1, mousepreventprogramspromoterprotein protein interactionresponsetoll-like receptor 4transcription factor
项目摘要
DESCRIPTION (provided by applicant): Overproduction of inflammatory mediators can lead to major organ failure and damage. The transcription of a defined set of inflammatory genes requires the simultaneous specific DNA-protein and protein-protein interactions in highly ordered complexes called enhanceosome. Poly(ADP-ribose) polymerase-1 (PARP-1) regulates transcription factors responsible for inflammatory gene expression, and importantly PARP-1-deficient (PARP-1-/-) mice were shown to be resistant to inflammatory diseases. The overall HYPOTHESES are that PARP-1 is recruited to the promoter, modifies transcription regulators with poly(ADP-ribose), and mediates recruiting transcription regulators to assemble the enhanceosome for synergistic gene transcription. Our SPECIFIC AIMS are to (1) determine whether PARP- 1 binds the iNOS promoter in a sequence-specific manner; (2) investigate if PARP-1 is recruited to the iNOS promoter by interacting with a sequence-specific transcription factor(s) and increasing its DNA binding activity; (3) investigate whether p42/44MAPK directly or indirectly phosphorylates and induces PARP-1 catalytic activity in response to LPS; (4) determine whether PARP-1 targets transcription regulators with poly(ADP-ribose) for the efficient gene transcription in response to LPS; (5) characterize PARP-1 mediating the recruitment of transcription regulators to the promoters (i) by comparing wild-type and PARP-1-/- cells, (ii) by simultaneously analyzing PARP-1-mediated recruitments, and (iii) of iNOS, TNFalpha, IL-1beta, and IL-6; and (6) definitively determine the specificity of PARP-1 and its catalytic activity on inflammatory gene regulation by expressing wild-type PARP-1 and catalytically inactive PARP-1 mutant in PARP-1-/- cells. The SIGNIFICANCE of the proposed studies is to offer new insights into the mechanism(s) by which PARP-1 may regulate and be regulated to achieve synergistic inflammatory gene transcription. The inflammatory gene transcription is critical for immune responses and for determining the onset of inflammatory diseases such as septic shock, acute lung inflammation, Alzheimer's disease, multiple sclerosis, and HIV-associated dementia.
描述(由申请人提供):炎症介质的过度产生可导致主要器官衰竭和损伤。一组确定的炎症基因的转录需要在称为增强体的高度有序的复合物中同时发生特异性DNA-蛋白质和蛋白质-蛋白质相互作用。聚(ADP-核糖)聚合酶-1(PARP-1)调节负责炎性基因表达的转录因子,重要的是,PARP-1缺陷(PARP-1-/-)小鼠显示出对炎性疾病的抗性。总的假设是PARP-1被募集到启动子,用聚(ADP-核糖)修饰转录调节子,并介导募集转录调节子以组装增强子用于协同基因转录。我们的具体目标是(1)确定PARP- 1是否以序列特异性方式结合iNOS启动子;(2)研究PARP-1是否通过与序列特异性转录因子相互作用并增加其DNA结合活性而被募集到iNOS启动子;(3)研究p42/44 MAPK是否直接或间接磷酸化并诱导PARP-1对LPS的催化活性;(4)确定PARP-1是否靶向具有多聚腺苷酸的转录调节子。(5)通过比较野生型和PARP-1-/-细胞,(ii)通过同时分析PARP-1介导的募集,和(iii)iNOS、TNF α、IL-1 β和IL-6,表征PARP-1介导的转录调节因子向启动子的募集;和(6)通过在PARP-1-/-细胞中表达野生型PARP-1和无催化活性的PARP-1突变体,确定PARP-1的特异性及其对炎症基因调节的催化活性。拟议研究的意义是为PARP-1可能调节和被调节以实现协同炎症基因转录的机制提供新的见解。炎性基因转录对于免疫应答和确定炎性疾病如感染性休克、急性肺部炎症、阿尔茨海默病、多发性硬化和HIV相关痴呆的发作至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MITCHELL C JUNG其他文献
MITCHELL C JUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MITCHELL C JUNG', 18)}}的其他基金
Epigenetic Regulation by Poly(ADP-ribose) in Response to Arsenite
聚(ADP-核糖)对亚砷酸盐的表观遗传调控
- 批准号:
7295735 - 财政年份:2006
- 资助金额:
$ 30.14万 - 项目类别:
Epigenetic Regulation by Poly(ADP-ribose) in Response to Arsenite
聚(ADP-核糖)对亚砷酸盐的表观遗传调控
- 批准号:
7172351 - 财政年份:2006
- 资助金额:
$ 30.14万 - 项目类别:
Role of PARP-1 in Mediating Inflammatory Gene Transcription
PARP-1 在介导炎症基因转录中的作用
- 批准号:
7535188 - 财政年份:2005
- 资助金额:
$ 30.14万 - 项目类别:
PARP-1 in Mediating Inflammatory Gene Transcript
PARP-1 在介导炎症基因转录中的作用
- 批准号:
7047605 - 财政年份:2005
- 资助金额:
$ 30.14万 - 项目类别:
Role of PARP-1 in Mediating Inflammatory Gene Transcription
PARP-1 在介导炎症基因转录中的作用
- 批准号:
7324835 - 财政年份:2005
- 资助金额:
$ 30.14万 - 项目类别:
Role of PARP-1 in Mediating Inflammatory Gene Transcription
PARP-1 在介导炎症基因转录中的作用
- 批准号:
7714358 - 财政年份:2005
- 资助金额:
$ 30.14万 - 项目类别:
Role of PARP-1 in Salmonella Pathogenesis
PARP-1 在沙门氏菌发病机制中的作用
- 批准号:
6766211 - 财政年份:2004
- 资助金额:
$ 30.14万 - 项目类别:
Role of PARP-1 in Salmonella Pathogenesis
PARP-1 在沙门氏菌发病机制中的作用
- 批准号:
6875004 - 财政年份:2004
- 资助金额:
$ 30.14万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 30.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 30.14万 - 项目类别:
Standard Grant